Publicaciones en las que colabora con José Ángel García Rodríguez (11)

2009

  1. Actividad in vitro de fosfomicina frente a enterobacterias de origen urinario productoras de betalactamasas de espectro extendido

    Revista Espanola de Quimioterapia, Vol. 22, Núm. 1, pp. 25-29

2007

  1. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229

2005

  1. Sensibilidad in vitro a los antibióticos y serotipos más frecuentes de Streptococcus pneumoniae. Estudio multicéntrico

    Revista Espanola de Quimioterapia, Vol. 18, Núm. 1, pp. 45-51

2004

  1. In vitro activity of older and newer fluoroquinolones against efflux-mediated high-level ciprofloxacin-resistant Streptococcus pneumoniae

    International Journal of Antimicrobial Agents, Vol. 24, Núm. 2, pp. 185-187

2003

  1. In vitro activity of newer antibiotics against Corynebacterium jeikeium, Corynebacterium amycolatum and Corynebacterium urealyticum

    International Journal of Antimicrobial Agents, Vol. 22, Núm. 5, pp. 492-496

2002

  1. In vitro activity of linezolid, synercid and telithromcin against genetically defined high level fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus

    International Journal of Antimicrobial Agents, Vol. 20, Núm. 1, pp. 61-64

2001

  1. Molecular diversity of quinolone resistance in genetically related clinical isolates of Staphylococcus aureus and susceptibility to newer quinolones

    Journal of Antimicrobial Chemotherapy, Vol. 47, Núm. 2, pp. 157-161

2000

  1. Actividad in vitro de nuevas quinolonas frente a cepas clinicas de Staphylococcus aureus silvestres y con mutaciones caracterizadas e n gyrA, gyrB y grlA

    Revista Espanola de Quimioterapia, Vol. 13, Núm. 3, pp. 271-275

1999

  1. Efflux pump-mediated quinolone resistance in staphylococcus aureus strains wild type for gyrA, gyrB, grlA, and norA

    Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 2, pp. 354-356

  2. In vitro activities of 13 fluoroquinolones against Staphylococcus aureus isolates with characterized mutations in gyrA, gyrB, grlA, and norA and against wild-type isolates

    Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 4, pp. 966-968

1998

  1. Analysis of grlA mutations in clinical isolates of Staphylococcus aureus with different levels of quinolone resistance [3]

    Antimicrobial Agents and Chemotherapy